C-terminal domain of SARS CoV 2 nucleocapsid protein binds transcriptional regulatory sequence RNA with high affinity and forms higher-order assemblies

Authors

Gupta, P., Singh, M.

Abstract

The SARS-CoV-2 nucleocapsid (N) protein is a 419-amino-acid modular protein essential for viral RNA replication, genome packaging, and host-cell modulation. It contains two structured domains, the N-terminal RNA-binding domain (NTD) and C-terminal dimerization domain (CTD), separated and flanked by three intrinsically disordered regions. Although the CTD mediates N-protein dimerization and contributes to RNA binding, the molecular basis of its interaction with RNA remains poorly understood. Here, we characterized CTD binding to transcriptional regulatory sequence (TRS) RNAs from the SARS-CoV-2 genome using NMR spectroscopy, isothermal titration calorimetry, size-exclusion chromatography, and in vitro phase-separation assays. The CTD bound structured stem-loop TRS RNA with higher affinity than the canonical RNA-binding NTD. NMR chemical-shift perturbation experiments indicated formation of higher-order molecular assemblies upon titration of the CTD with longer, structured stem-loop TRS RNA, consistent with size-exclusion chromatography results. The CTD also underwent RNA-induced phase separation in vitro, with stem-loop TRS RNA promoting markedly more robust condensation than single-stranded RNA sequences. Together, these findings establish the CTD as a high-affinity, structure-selective RNA-binding domain with a preference for stem-loop TRS RNA. The results further show that CTD-TRS interactions promote higher-order assembly and phase separation, providing mechanistic insight into N-protein-mediated viral genome packaging and nucleocapsid assembly.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 06 Oct 2026.

Stats

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.